ethinyl estradiol-norgestrel combination and oxyntomodulin

ethinyl estradiol-norgestrel combination has been researched along with oxyntomodulin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flint, A; Hartvig, H; Jensen, CB; Jensen, L; Kapitza, C; Nosek, L	1

Other Studies

1 other study(ies) available for ethinyl estradiol-norgestrel combination and oxyntomodulin

Article	Year
Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel. Journal of clinical pharmacology, 2015, Volume: 55, Issue:5 Topics: Aged; Area Under Curve; Blood Glucose; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Glucagon-Like Peptides; Glycated Hemoglobin; Half-Life; Humans; Hypoglycemic Agents; Levonorgestrel; Metabolic Clearance Rate; Middle Aged; Postmenopause	2015

Article

Year

Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel.

Journal of clinical pharmacology, 2015, Volume: 55, Issue:5

Topics: Aged; Area Under Curve; Blood Glucose; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Glucagon-Like Peptides; Glycated Hemoglobin; Half-Life; Humans; Hypoglycemic Agents; Levonorgestrel; Metabolic Clearance Rate; Middle Aged; Postmenopause

2015